Home / Solutions / Vaccine Type / Fungal Vaccines
Vaccine Type
Live Attenuated and
Killed Vaccines
Subunit Vaccines
Hapten Conjugate
Vaccines
Totally Synthetic
Vaccines
DNA and RNA
Vaccines
Viral Vector
Vaccines
Bacterial Vector
Vaccines
Virus-Like Particles
Based Vaccines
Cell Based Vaccines
Plant-based
Vaccines
Bacterial Vaccines
Viral Vaccines
Fungal Vaccines
Parasitic Vaccines
HBV Vaccines
Fungal Vaccines
Fungi organisms are prevalent in the environment. Pathogenic fungi,
although relatively few in the field of microbial pathogen, can cause varying
degrees of severity disease in individuals with normal or impaired immunity.
Creative Biolabs can offer high-quality Fungal Vaccines for use in prevention
of fungal infections. Invasive fungal infections have become more frequent
over the past 50 years as the prevalence of immunocompromised increases.
The high mortality caused by invasive fungal disease and high morbidity due
to intractable mucosal infection have led to an unmet need for innovative
prevention and treatment strategies against fungal pathogens. Several
vaccines are being developed to address this need.
DC Vaccines
Human tumors express
a large number of
protein antigens that
can be recognized by T
cells, which provide
potential targets for
cancer immunotherapy.
Dendritic cells (DCs) are
rare leukocytes which have unique ability to present antigens to T cells
effectively, and this property contributes to its recent use in therapeutic
cancer vaccines. DC vaccine involves incubating or“pulsing” DCs ex vivo with
select antigens or pathogens, then returning the cells to the host to boost
protection against an infectious agent. DC vaccination requires that the
treatment be performed before infection. DCs are activated after sensing
pathogen associated molecular patterns through pattern recognition
receptors (PRRs), which induce the up-regulation of cytokines and
costimulatory proteins. These proteins engage their receptors on the surface
of T cells that recognize antigens presented by DCs on major